SCHEMBL19079682

SCHEMBL19079682

O=C(CCc1nc2sc(-c3ccc(F)cc3)cc2c(=O)n1C1CC1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 1/20 0.42
▸ HSD11B1 P28845 2/20 0.42
▸ NPC1 O15118 9/20 0.40
▸ RAB9A P51151 9/20 0.40
▸ KDM4E B2RXH2 6/20 0.40
▸ SMN1; SMN2 Q16637 6/20 0.40
▸ HPGD P15428 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ALDH1A1 P00352 6/20 0.39
▸ MAPT P10636 5/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ CASP3 P42574 2/20 0.39
▸ SENP8 Q96LD8 2/20 0.39
▸ SENP7 Q9BQF6 2/20 0.39
▸ SENP6 Q9GZR1 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ SIGMAR1 Q99720 2/20 0.38
▸ NFKB1 P19838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079771 0.84 PDE4D (0.64) PDE4DNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL19079884 0.78 PDE4D (0.66) PDE4DHSD11B1NPC1RAB9ASMN1; SMN2
SCHEMBL21133089 0.75 PDE4D (0.64) PDE4DNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL19079703 0.75 PDE4D (0.64) PDE4DNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL19090388 0.73 PDE4D (0.61) PDE4DNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL19079688 0.69 PDE4D (0.58) PDE4DKDM4ESMN1; SMN2HPGDCYP1A2
SCHEMBL653372 0.65 CNR2 (0.48) HSD11B1KDM4ESMN1; SMN2HPGDALDH1A1
SCHEMBL655174 0.61 ALDH1A1 (0.85) NPC1RAB9AKDM4ESMN1; SMN2HPGD
SCHEMBL659281 0.60 NPC1 (0.59) HSD11B1NPC1RAB9AKDM4EALDH1A1
SCHEMBL4485908 0.60 RAB9A (0.69) HSD11B1NPC1RAB9AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885HSD11B1 1310/4885NPC1 3480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback